Use of a bicyclo-2.2.2-octane-2-carboxylate salt in the manufacture of a medicament for treating dysphoria, liver dysfunction and a disease associate with an elevated erthrocyte sedimentation rate

摘要

Administration of a salt of bicyclo [2.2.2] octane-2-carbonic acid reduces dysphoria in dysphoric subjects, ameliorates ethanol craving in alcoholics, reduces the erythrocyte sedimentation rate and the level of liver function markers (AST, ALT, and bilirubin) in human subjects, and reduces the number or strength of seizures in epileptics.